ClinicalTrials.gg
RecruitingNCT06302335Updated Mar 8, 2024

Povidone-iodine vs Saline Solution in Colorectal Surgeries and Its Effects on the Surgical Site Infection

A Phase 3 interventional study of Povidone-iodine and Saline solution in Surgical Site Infection, sponsored by Hospital de Clinicas de Porto Alegre. Recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-08.

Sponsored by Hospital de Clinicas de Porto Alegre · Phase 3, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Jan 2023, registered Mar 2024).
  • Started Jan 2023; still recruiting 3 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
228
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies testing Povidone-Iodine in Surgical Wound Infection — 4 open to participants now, 5 under way, 2 of them phase 3. Povidone-Iodine · Surgical Wound Infection.

Planned enrollment
9th of 18
228 · median 210
Started
2023
the only one that year
Phase 3
3 of 18
2 open now
Registered
15th of 18
by date
Lead sponsor
1 of 18
Hospital de Clinicas de Porto Alegre

Among the 18 studies testing Povidone-Iodine in Surgical Wound Infection, this one is the 9th largest by planned enrollment, is the only one that started in 2023, is one of 3 in phase 3, and was the 15th registered.

Surgical Wound Infection

747 studies on the registry are indexed under Surgical Wound Infection; 152 are open to participants now.

Browse Surgical Wound Infection studies →

Open to participants now

4 of the 18 studies testing Povidone-Iodine in Surgical Wound Infection are open now, in 4 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

About Povidone-Iodine

Povidone-Iodine: first FDA approval 1985 (E-Z SCRUB 201). What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 85 Surgical Wound Infection studies recruiting now, 62 (73%) set no upper age limit and 16 (19%) stop at 75 or younger; 12 take children under 18; 14 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies testing Povidone-Iodine in Surgical Wound Infection, or all of them as a file.
02

Study summary

Considering the relatively high incidence of surgical site infection (SSI) in colorectal surgery, this trial will compare rates of SSI in patients undergoing colorectal resections followed by surgical wound irrigation with povidone-iodine versus the group of patients undergoing surgical wound irrigation with saline solution. The trial will be conducted in a large university hospital in Southern Brazil.

Read the detailed description

Patients will be randomized to one of the following intervention groups:

Group 1: intraoperative irrigation/washing of the surgical incision with povidone-iodine (PVP-I); Detail: after aponeurotic synthesis and immediately before cutaneous synthesis, the skin and subcutaneous tissue of the surgical incision will be irrigated and washed abundantly with approximately 500ml (depending on the size of the incision) of povidone-iodine solution (PVP-I). The exact volume to be used will be the minimum volume necessary for abundant and efficient washing of the incision tissues. " Group 2: intraoperative irrigation/washing of the surgical incision with saline solution (NaCl 0.9%); Detail: after aponeurotic synthesis and immediately before cutaneous synthesis, the skin and subcutaneous tissue of the surgical incision will be irrigated and washed abundantly with approximately 500ml (depending on the size of the incision) of saline solution (NaCl 0.9%). The exact volume to be used will be the minimum volume necessary for abundant and efficient washing of the incision tissues.

NOTE: other care routines for participating patients will not be changed by this study. Patients will receive mechanical colon preparation and antibiotic prophylaxis according to routines already in place by the assistant team.

Randomization: the block randomization method will be used (blocks of 4 patients each).

Groups 1 and 2 will be compared with each other regarding the outcomes.

03

Conditions studied

  • Surgical Site Infection

Keywords

  • surgical site infection
  • colorectal surgey
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patients older than 18 years of age diagnosed with benign or malignant colorectal diseases undergoing elective open or video-assisted colectomy or proctectomy (resection) at the Hospital de Clinicas de Porto Alegre - Division of Coloproctology.

Exclusion criteria

Exclusion Criteria:

  • age under 18;
  • surgery classified as dirty;
  • urgent/emergency surgery;
  • patients undergoing multi-visceral resections (pelvic exenteration or partial resection of any adjacent organ);
  • known allergy to iodine.
05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
228 participants (estimated)

Study arms

  • Experimental
    Povidone-iodine arm

    Patients submitted to colorectal resections using Povidone-iodine in the surgical wound.

    Drug: Povidone-iodine

  • Active comparator
    Saline solution arm.

    Patients submitted to colorectal resections using saline solution in the surgical wound.

    Drug: Saline solution

Interventions

  • Application of Povidone-iodine to the surgical wound of patients submitted to colorectal resections.

  • DrugSaline solution

    Application of saline solution to the surgical wound of patients submitted to colorectal resections.

06

What researchers measure

Primary outcomes

  1. Surgical site infection

    Surgical site infection within 30 days from the surgical procedure

    Time frame: 30 days

Secondary outcomes

  1. Intracavitary surgical infection

    Infections within the abdominal cavity

    Time frame: 30 days

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2023 (actual). Primary completion is estimated for Dec 2027, 59 months after the start.

Of 38 phase 3 interventional studies under Surgical Wound Infection, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 51. This study's planned 59 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 4, 2024
First posted
Mar 8, 2024
StartActual
Jan 2, 2023
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2027
Last update
Mar 8, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06302335
Responsible party
Sponsor
First posted
Mar 8, 2024
Start date
Jan 2, 2023
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Mar 8, 2024

Study contacts

Daniel C Damin, PhD
Contact
damin@terra.com.br
+5551996020442
Daniel C Damin, PhD
principal investigator · Hospital de Clínicas de Porto Alegre

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Povidone-Iodine

Start the discussion